(19)
(11) EP 0 828 737 A1

(12)

(43) Date of publication:
18.03.1998 Bulletin 1998/12

(21) Application number: 96920476.0

(22) Date of filing: 24.05.1996
(51) International Patent Classification (IPC): 
A61K 31/ 42( . )
A61K 31/ 505( . )
A61P 9/ 14( . )
C07D 413/ 06( . )
C07D 413/ 14( . )
C07D 417/ 12( . )
A61K 31/ 44( . )
A61P 7/ 02( . )
A61P 43/ 00( . )
C07D 413/ 12( . )
C07D 417/ 06( . )
C07D 471/ 04( . )
(86) International application number:
PCT/US1996/007646
(87) International publication number:
WO 1996/037492 (28.11.1996 Gazette 1996/52)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 25.05.1995 US 19950450646
31.05.1995 US 19950455768
09.05.1996 US 19960647132

(71) Applicant: THE DU PONT MERCK PHARMACEUTICAL COMPANY
Wilmington, Delaware 19898 (US)

(72) Inventors:
  • VOSS, Matthew, Ernst
    Lincoln University, PA 19352-9112 (US)
  • JADHAV, Prabhakar, Kondaji
    Wilmington, DE 19808-4314 (US)
  • SMALLHEER, Joanne, Marie
    Landenberg, PA 19350-9368 (US)
  • BATT, Douglas, Guy
    Wilmington, DE 19803-2615 (US)
  • PITTS, William, John
    Newark, DE 19711-8309 (US)
  • WITYAK, John
    West Grove, PA 19390-9439 (US)

(74) Representative: Pett, Christopher Phineas, et al 
Frank B. Dehn & Co., European Patent Attorneys, 179 Queen Victoria Street
London EC4V 4EL
London EC4V 4EL (GB)

   


(54) ISOXAZOLINE AND ISOXAZOLE DERIVATIVES AS INTEGRIN RECEPTOR ANTAGONISTS